Cor Vasa 2026, 68(2):166-172 | DOI: 10.33678/cor.2025.133
Clinical predictors of appropriate electrical storm in patients with implantable cardioverter defibrillator
- a Al-Basrah Cardiac Centre, Basra, Iraq
- b Ibn Al-Bitar Cardiac Centre, Baghdad, Iraq
- c College of Medicine, University of Diyala, Iraq
Background: Appropriate electrical storm (ES) in patients with implantable cardioverter-defi brillators (ICDs) is a life-threatening condition characterized by recurrent, appropriate ICD therapies; antitachycardia pacing (ATP) and/or shocks; within a 24-hour period. Some authors defi ne ES as three or more VT/VF episodes separated by at least 5 minutes of sinus rhythm. ICD shocks have signifi cant adverse effects, and available evidence indicates that patients experiencing ES have poorer outcomes. Potential triggers include changes in or non-adherence to medication, worsening heart failure, early postoperative states, emotional stress, alcohol excess, electrolyte imbalances, myocardial ischemia, and less common factors such as fever. However, many ES episodes occur without any identifi able cause.
Objectives: This study aimed to evaluate clinical predictors of appropriate electrical storm in patients with ICDs.
Patients and methods: This single-center, retrospective, observational case-control study was conducted at Ibn-Albitar Specialist Center for Cardiac Surgery from April 1, 2016 to January 1, 2017. Twenty-fi ve consecutive ICD patients admitted with appropriate electrical storm were included as the case group and compared with 25 ICD recipients without ES who attended the center for routine programming and follow-up.
Results: A total of 50 ICD patients were analyzed: 25 with ES (cases) and 25 without ES (controls). The mean ages of the case and control groups were 54 ± 12.09 years and 54.8 ± 12.19 years, respectively. Males constituted 84% of the case group and 40% of the control group. Hypertension was present in 56% of cases and 36% of controls, and diabetes was present in 36% of both groups. Ischemic heart disease was more prevalent among cases (80%) than controls (44%). Left ventricular ejection fraction (LVEF) < 40% was found in 80% of cases compared with 44% of controls. Recent heart failure decompensation (within 1 month) occurred in 56% of cases and only 8% of controls.
Regarding ICD indication, secondary prevention accounted for 80% of cases and 84% of controls. ICD-VR devices were more common in cases (84%) than in controls (44%), while ICD-DR devices were less frequent in cases (16%) versus controls (56%). Systolic heart failure was present in 80% of both groups. Other etiologies included HOCM (2 cases/2 controls), short QT syndrome (2 cases/2 controls), and Noonan syndrome (1 case/1 control). Obesity (BMI > 30) was more prevalent in cases (68%) than in controls (16%). Fever > 38 °C at the time of ES was documented in 28% of cases, with none reported in controls. Current smoking was more common among cases (56%) than controls (40%). Heavy alcohol use occurred in 4% of both groups. Thyroid function was normal across all subjects. Hypokalemia (< 3.5 mmol/L) was present in 64% of cases and 24% of controls, while low magnesium (< 1.6 mg/dL) was found in 64% of cases versus 24% of controls. No early cardiac or non-cardiac surgical interventions had occurred within 6 months in either group.
Conclusion: Electrical storm is a relatively common complication that may occur at any point after ICD implantation and may recur. The study identifi ed several predictors of ES, including reduced LVEF, ICD implantation for secondary prevention, electrolyte disturbances, and absence of amiodarone or ACE-inhibitor therapy.
Keywords: ACE-inhibitors, Amiodarone, Electrical storm, Electrolyte disturbances, ICD implantation
Received: February 15, 2025; Revised: December 4, 2025; Accepted: December 11, 2025; Prepublished online: June 2, 2012; Published: May 20, 2026 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Elsokkari I, Sapp JL. Electrical storm: prognosis and management. Prog Cardiovasc Dis 2021;66:70-79.
Go to original source...
Go to PubMed... - Ellenbogen KA, Levione JH, Berger RD, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-782.
Go to original source... - Guerra F, Shkoza M, Flori M, Capucci A. Electrical Storm. Cardiac Arrhythmias - New Considerations. InTech, 2012.
Go to original source... - Sesselberg HW, Moss AJ, McNitt S, et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007;4:1395-1402.
Go to original source...
Go to PubMed... - Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004;43:2293-2299.
Go to original source...
Go to PubMed... - Song PS, Kim JS, Shin DH, et al. Electrical Storms in Patients with an Implantable Cardioverter Defibrillator. Yonsei Med J 2011;52:26-32.
Go to original source... - Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-707.
Go to original source... - Streitner F, Kuschyk J, Veltmann C, et al. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace 2011;13:668-674.
Go to original source...
Go to PubMed... - European Heart Rhythm Association; Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-e346.
- Greene HL. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. Am J Cardiol 1993;72:70F-74F.
Go to original source...
Go to PubMed... - Sagone A. Electrical Storm: Incidence, Prognosis and Therapy. J Atr Fibrillation 2015;8:1150.
- Dorian P, Cass D. An overview of the management of electrical storm. Can J Cardiol 1997;13:13A-17A.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.




